Race against time: finding the best drug to stop newborn seizures
NCT ID NCT07284498
Summary
This study aims to find out which of two common seizure medications works better and is safer for newborns who have seizures due to brain injury from lack of oxygen during birth (HIE). It will compare phenobarbital against two different doses of a newer drug called levetiracetam. The goal is to control the seizures quickly to prevent further brain damage and see which medicine causes fewer side effects for the baby's heart, breathing, and other organs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEIZURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Al Galaa Teaching Hospital
Cairo, Egypt
-
University Children's Hospital, Mansoura University
Al Mansurah, Egypt
Conditions
Explore the condition pages connected to this study.